Log In
BCIQ
Print this Print this
 

Cardicor, bisoprolol

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionAdrenergic receptor beta 1 (ADRB1) blocker
Molecular Target Adrenergic receptor beta 1 (ADRB1)
Mechanism of ActionAdrenergic receptor beta 1 (ADRB1) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHeart failure
Indication DetailsTreat heart failure associated with reduced systolic ventricular function
Regulatory Designation
PartnerRecordati S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/03/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today